Predicting Diseases Using Genetic Markers Could be a Game Changer

This is what companies around the world are attempting to do as they dive deeper into the genomics industry to find the key behind chronic inflammation. It has often been referred to as a silent killer and is a starting point for many different diseases and illnesses. Investors looking to hit a homerun with a speculative biotech or pharmaceutical company will want to consider some of the following stocks. 

In this industry, the companies with the deepest pockets have the longest runway for success. Companies like Pfizer (NYSE:PFE), Johnson & Johnson (NYSE:JNJ), and AbbVie (NYSE:ABBV) are all heavily inverted and involved in finding a treatment for inflammation. 

Perhaps more interesting is the recently changed company Ludwig Enterprises (OTC:LUDG). Ludwig is forging partnerships like one with Emerson Urology Associates where its upcoming Ludwig mRNA Inflammatory Index will be used when it is ready. It is also using the data from this index to create early indications and triggers for early detection of diseases like cancer, strokes, and heart disease. These advancements from Ludwig are tremendous and could lead to a future where life expectancy is lengthened and difficult and traumatic battles against diseases are reduced significantly. 

Featured: $LUDG $PFE $JNJ $ABBV 




Stay Connected
Latest News
From Sponsor
PubCo Insight. Deep Intelligence
Including AI Reports
for Savvy Investors

If you’re looking for a way to get an edge on the stock market, you need to check out PubCo Insight. Using AI, our system is able to make highly accurate stock picks that can help you achieve major gains. With our AI Reports, you’ll be able to learn which stocks are the most traded, undervalued, and have the most potential for growth. This valuable information is absolutely essential for anyone who wants to be successful in the stock market. So sign up now and get started on your path to success!

%d bloggers like this: